Immunotherapy trial for rectal cancer offers hope for future – CBS News
A small immunotherapy trial for a certain type of rectal cancer reports a 100% success rate. Dr. Jon LaPook explains how it’s designed to work, and how it could be used as a model to treat other cancers.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Roborop is an online news website focused on delivering news on the latest technology, apps , software, Business, Automobile and health. We bring you the latest facts and information that is mostly hidden from the eyes of a common man. If you would like to contribute on my website, please visit the ‘Write for Us guidelines page.